A detailed history of Nikko Asset Management Americas, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 8,471 shares of VRTX stock, worth $3.46 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,471
Previous 11,820 28.33%
Holding current value
$3.46 Million
Previous $5.54 Million 28.9%
% of portfolio
0.05%
Previous 0.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$460.0 - $505.78 $1.54 Million - $1.69 Million
-3,349 Reduced 28.33%
8,471 $3.94 Million
Q2 2024

Aug 09, 2024

SELL
$392.81 - $485.53 $1.26 Million - $1.56 Million
-3,212 Reduced 21.37%
11,820 $5.54 Million
Q1 2024

May 02, 2024

SELL
$407.69 - $446.08 $1.02 Million - $1.12 Million
-2,507 Reduced 14.29%
15,032 $6.28 Million
Q4 2023

Feb 08, 2024

SELL
$343.0 - $410.68 $422,919 - $506,368
-1,233 Reduced 6.57%
17,539 $7.14 Million
Q3 2023

Nov 09, 2023

SELL
$338.18 - $362.46 $48,359 - $51,831
-143 Reduced 0.76%
18,772 $6.53 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $204,687 - $229,093
651 Added 3.56%
18,915 $6.66 Million
Q1 2023

May 03, 2023

SELL
$283.23 - $323.1 $393,406 - $448,785
-1,389 Reduced 7.07%
18,264 $5.75 Million
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $1.41 Million - $1.59 Million
-4,951 Reduced 20.12%
19,653 $5.68 Million
Q3 2022

Nov 14, 2022

SELL
$273.83 - $305.53 $6.84 Million - $7.63 Million
-24,981 Reduced 50.38%
24,604 $7.08 Million
Q2 2022

Aug 04, 2022

SELL
$234.96 - $292.55 $7.51 Million - $9.35 Million
-31,950 Reduced 39.19%
49,585 $13.6 Million
Q1 2022

May 06, 2022

SELL
$221.42 - $260.97 $7.19 Million - $8.47 Million
-32,454 Reduced 28.47%
81,535 $21.4 Million
Q4 2021

Feb 08, 2022

SELL
$177.01 - $223.45 $2.34 Million - $2.95 Million
-13,207 Reduced 10.38%
113,989 $24.9 Million
Q3 2021

Nov 09, 2021

BUY
$181.39 - $202.99 $3.47 Million - $3.88 Million
19,115 Added 17.69%
127,196 $23.1 Million
Q2 2021

Aug 09, 2021

SELL
$187.49 - $221.1 $2.84 Million - $3.35 Million
-15,166 Reduced 12.31%
108,081 $21.7 Million
Q1 2021

May 03, 2021

BUY
$207.02 - $241.31 $7 Million - $8.16 Million
33,798 Added 37.78%
123,247 $26.5 Million
Q4 2020

Feb 11, 2021

BUY
$207.01 - $276.09 $1.13 Million - $1.51 Million
5,457 Added 6.5%
89,449 $21.1 Million
Q3 2020

Nov 02, 2020

BUY
$255.65 - $303.1 $5.48 Million - $6.5 Million
21,429 Added 34.25%
83,992 $22.5 Million
Q2 2020

Aug 07, 2020

SELL
$225.48 - $295.8 $10.8 Million - $14.2 Million
-47,860 Reduced 43.34%
62,563 $17.7 Million
Q1 2020

Apr 30, 2020

SELL
$199.77 - $247.81 $2.49 Million - $3.09 Million
-12,467 Reduced 10.14%
110,423 $26.3 Million
Q4 2019

Feb 06, 2020

SELL
$166.71 - $223.91 $544,141 - $730,842
-3,264 Reduced 2.59%
122,890 $26.9 Million
Q3 2019

Oct 29, 2019

BUY
$166.23 - $187.09 $3.42 Million - $3.85 Million
20,594 Added 19.51%
126,154 $21.4 Million
Q2 2019

Jul 29, 2019

BUY
$164.61 - $190.37 $10.2 Million - $11.8 Million
62,110 Added 142.95%
105,560 $19.4 Million
Q1 2019

Apr 30, 2019

BUY
$163.73 - $194.7 $7.11 Million - $8.46 Million
43,450 New
43,450 $7.99 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.